Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DURHAM, N.C., April 26, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that Kenneth I. Moch, its President and Chief Executive Officer, will present a company overview at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 3:00 p.m. ET at the Westin New York Grand Central Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
DURHAM, N.C., April 26, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that Kenneth I. Moch, its President and Chief Executive Officer, will present a company overview at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 3:00 p.m. ET at the Westin New York Grand Central Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
